Health Economic Evaluation Of Elective Cardioversion Of Atrial Fibrillation With Rivaroxaban Versus Vitamin K Oral Antagonists
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1235
https://www.valueinhealthjournal.com/article/S1098-3015(17)31569-3/fulltext
Title :
Health Economic Evaluation Of Elective Cardioversion Of Atrial Fibrillation With Rivaroxaban Versus Vitamin K Oral Antagonists
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31569-3&doi=10.1016/j.jval.2017.08.1235
First page :
A616
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1180